Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Arcus Biosciences, Inc. (RCUS)Equibles does not estimate personal net worth.
Get an email with a short summary when Arcus Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get RCUS alertsPia Eaves is recorded as Head of Investor Relations at Arcus Biosciences, Inc. (RCUS). Pia Eaves has spoken on 6 earnings calls across 1 company, most recently for Arcus Biosciences, Inc. on August 5, 2026. Arcus Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arcus Biosciences, Inc. includes Terry Rosen (CEO and Board Member), Robert C. Goeltz II (CFO and Chief Accounting Officer), Robert Goeltz (CFO) and 7 others.
“Good afternoon and thank you for joining us on today's conference call to discuss ARCISO's second quarter 2026 financial results and pipeline updates.”
“Good afternoon and thank you for joining us on today's conference call to discuss ARCIS's first quarter 2025 financial results and pipeline updates.”
“Hello, everyone, and thank you for joining us on today's conference call to discuss Arcus' third quarter 2024 financial results and pipeline updates, including our upcoming presentation.”
“Hello, everyone, and thank you for joining us on today's conference call to discuss Arcus' First Quarter 2024 Financial Results and Pipeline Updates.”
“Hello, everyone and thank you for joining us on today’s conference call to discuss Arcus’s fourth quarter 2023 financial results and pipeline updates.”
Biotechnology · Healthcare
Head of Investor Relations